Intro

This chapter investigates the alarming lack of proven effectiveness in many FDA-approved drugs, revealing that nearly 75% failed to meet scientific standards from 2013 to 2022. It discusses the historical context of lenient approval processes stemming from the AIDS crisis and their implications for patient safety.